- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Covid19 in France
Total 902 results
-
University of ManitobaUniversity Health Network, TorontoCompletedCOVID-19 | PneumoniaUnited States, Brazil, Canada, Mexico
-
Karyopharm Therapeutics IncCompletedCoronavirus InfectionUnited States, Spain, France, United Kingdom, Israel, Austria
-
Boehringer IngelheimTerminatedCOVID-19Spain, United States, Mexico, Brazil, Chile, Puerto Rico
-
Ansun Biopharma, Inc.RecruitingCOVID-19 | Lower Respiratory Tract Infection | Immunocompromised | ParainfluenzaUnited States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
AmgenCompletedCOVID-19United States, Russian Federation, Mexico, Brazil, South Africa, Argentina, Chile, Ukraine
-
University Hospital, ToursCompletedCOVID-19 | Acute Respiratory Distress SyndromeFrance
-
Centre Hospitalier Intercommunal CreteilAssociation Clinique Thérapeutique Infantile du val de Marne; GPIP; Francophone... and other collaboratorsRecruiting
-
Brazilian Clinical Research InstituteHospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaboratorsCompletedCoronavirus InfectionBrazil
-
Ictal GroupUnknownCOVID-19 | Critically Ill | EncephalopathyEgypt, France, United States, Brazil, Colombia, Mexico, Spain
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Hospital Alemão Oswaldo CruzBayer; Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Brazilian... and other collaboratorsTerminated
-
Cardiol Therapeutics Inc.TerminatedCardiovascular Diseases | COVID-19 | Cardiovascular Risk FactorUnited States, Brazil, Mexico
-
Regeneron PharmaceuticalsTerminated
-
Ottawa Heart Institute Research CorporationActive, not recruiting
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
Sanofi Pasteur, a Sanofi CompanyGlaxoSmithKlineCompletedCOVID-19Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom
-
Gilead SciencesTerminatedCOVID-19Spain, Japan, Korea, Republic of, Taiwan, Bulgaria, Mexico, South Africa, United Kingdom, Portugal, Romania, Hungary, Brazil, Canada, France, Italy, Poland, Singapore, Turkey
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
EmitBio Inc.Recruiting
-
EyePoint Pharmaceuticals, Inc.Medical Technology Enterprise Consortium (MTEC)TerminatedCOVID-19 | Acute Respiratory Distress Syndrome (ARDS)United States
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, Belgium, France, Spain, United Kingdom
-
Centre Hospitalier St AnneLaboratoire français de Fractionnement et de Biotechnologies; Groupe Hospitalier...CompletedCOVID-19 | Acute Respiratory Distress SyndromeFrance
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
Saint Luke's Health SystemAstraZeneca; George Clinical Pty Ltd; Saint Luke's Hospital of Kansas CityCompletedCOVID-19United States, Brazil, Argentina, India, Canada, Mexico, United Kingdom
-
Hospital Alemão Oswaldo CruzHospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaboratorsCompleted
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Denmark, Japan, Mexico, Spain, Korea, Republic of, Germany, Greece, Singapore, United Kingdom
-
MediMergent, LLCTerminatedSARS-CoV-2 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19Korea, Republic of, United States, Denmark, Japan, Mexico, Singapore, Spain, United Kingdom
-
ShionogiRecruitingSARS-CoV-2 InfectionJapan, United States
-
Invivyd, Inc.TerminatedCOVID-19Argentina, Brazil, Bulgaria, Germany, Greece, Hungary, Moldova, Republic of, Poland, Romania, South Africa, Ukraine
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
PfizerCompletedCOVID-19United States, Taiwan, Italy, Canada, Greece
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
PfizerCompletedCOVID-19Spain, United States, Australia, Canada, Bulgaria, Slovakia, Mexico, Hungary, Brazil
-
Eli Lilly and CompanyCompletedCOVID-19United States, Spain, India, Germany, Puerto Rico, Brazil, Korea, Republic of, Argentina, Italy, Japan, Mexico, Russian Federation, United Kingdom
-
PfizerSuspendedCOVID-19United States, United Kingdom, Japan, South Africa, Bulgaria, Puerto Rico, Mexico, Hungary
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...CompletedCOVID-19United States, Puerto Rico, Argentina
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Population Health Research InstituteBayerCompletedSevere Acute Respiratory Syndrome | CoronavirusEgypt, Canada, Brazil, Colombia, Ecuador, India, Nepal, Pakistan, Philippines, Russian Federation, South Africa, United Arab Emirates
-
NeuroActiva, Inc.Biomed Industries, Inc.RecruitingCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory InfectionUnited States
-
BioNTech SEPfizerRecruiting
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of